Diartis purchased Versartis' Type II diabetes candidate VRS-859 (exenatide-XTEN) and an undisclosed compound

Versartis Inc.

U.S. / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Diartis Pharmaceuticals Inc.

U.S. / Private Biopharma

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced